3.95 USD
▼-0.01-0.75%
2026-08-03
市值
$7.59M
市盈率
—
EPS
-16.34
股息率
—
52 周区间
3.75 – 7.20
成交量
2.31K
Beta
1.17
目标价
41.00
52W 低 3.7552W 高 7.20
价格走势
公司简介
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company’s pipeline products include BDC-4182, a next-generation Boltbody ISAC that targets the tumor-associated antigen claudin 18.2 for the treatment of gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types; BDC-3042, a dectin-2 agonist antibody program for the treatment of non-small cell lung cancer, melanoma, and other solid tumors; CEA ISAC, a Boltbody ISAC targeting carcinoembr...